- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04985175
Impact of Decision Quality by Using Question Prompt List
August 1, 2021 updated by: National Taiwan University Hospital
Impact of Decision Quality by Using Question Prompt List on the Shared Decision Making in End-stage Renal Disease Patients
To investigate the effects of a question prompt list (QPL) on a shared decision-making consultation among facing decision for dialysis in end-stage renal disease (ESRD) patients.
A randomized controlled trial was conducted at the university medical center of North Taiwan.
Subjects were randomized assigned to QPL group or usual care group.
Decisional quality and decision control preferences were assessed with questionnaires.
Measurements were performed at before the counseling (T0), immediately after counseling (T1), and evaluate decision regret at one month after treatment.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
The aim of this study was to investigate the effectiveness of decisional quality and decisional control preferences by using a specific question prompt list (QPL) during a shared decision-making consultation among facing decision for dialysis in end-stage renal disease (ESRD) patients.
A randomized controlled trial was conducted at the university medical center of North Taiwan.
Recruit subjects are those who are about to receive the nurse-led coaching of shared decision-making (SDM) for patients with ESRD and attend the program.
By using blocked Randomization design, the investigators assigned participants to QPL group or usual care.
Prior to a clinic visit to discuss treatment, two-pages ESRD QPL leaflets are provided to QPL group, while usual care group without receiving provision of QPL.
Measurements of outcome included decision quality (decision conflict, decisional self-efficiency) and decision control preference at before the counseling (T0), immediately after counseling (T1), and evaluate decision regret at one month after treatment (T2), at this time the patient has decided and started to accept the selected treatment (hemodialysis, peritoneal dialysis or conservative treatment).
All statistical analyses were performed in SAS statistical software, version 9.4 (SAS, Cary, NC).
The effects of the intervention were assessed by generalized estimating equation (GEE) analysis with the coefficient of interaction ( group × time) term.
Statistical tests were two-sided with a significance level of 0.05.
Hierarchical Linear Model was used to detect the impact of nested within physician.
Study Type
Interventional
Enrollment (Anticipated)
154
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Xindian
-
Taipei City, Xindian, Taiwan, 231
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with stage 5 chronic kidney disease who facing decision for dialysis;
- normal cognitive functions;
- be able to read, communicate in Mandarin or Taiwanese;
- ability to express willingness;
Exclusion Criteria:
- vision or hearing function impairment;
- Severe illness;
- Urgent to dialysis for extend life;
- Dialysis modalities Already decided.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: QPL group
receive 2-pages ESRD QPL leaflets, circle the questions they want to ask before consultation.
encourage asking questions with doctor during consultation.
receive the nurse-led coaching of shared decision-making (SDM)
|
The specific QPS was a one page leaflet for chronic kidney disease which developed by applied literature and public QPL from the National Health Agency.
It contains 3 domains 25 questions related to treatment, dialysis, and Kidney transplant.
The QPL group participants were asked to read and mark those questions they concerned or write down additional problems.
|
|
No Intervention: Usual care group
without receiving provision of QPL encourage asking questions with doctor during consultation.
receive the nurse-led coaching of shared decision-making (SDM)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Decision conflict
Time Frame: before the counseling (T0), immediately after counseling(T1)
|
Decision conflict was measured by Decision conflict scale(DCS).
The scale consists of 16 items into 5 subscales: Uncertainty(3 items), Informed(3 items), values clarity(3 items), support(3 items), and effective decision(4 items) that are rated on a 5-point likert-scale from "strongly agree" (0) to "strongly disagree" (4).
The sum of scores are calculated from 0 to 100.
The higher the score, the higher the level of decision conflict.
|
before the counseling (T0), immediately after counseling(T1)
|
|
Decisional self-efficiency
Time Frame: before the counseling (T0), immediately after counseling(T1)
|
Decision self-efficiency was measured by Decisional Self-Efficiency Scale(DSES).
The scale represents self-confidence or belief in decision making.
The scale consists of 11 items that are rated on a 5-point likert-scale from "not at all confident" (0) to" very confident "(4) .
The sum of scores are calculated from 0 to 100.
The higher the score, the higher the level of self-confidence.
|
before the counseling (T0), immediately after counseling(T1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Decision control preference
Time Frame: one month after treatment (T2)
|
Decision regret was measured by Decision regret Scale(DRS) .The scale consists of 5 items that are rated on a 5-point likert-scale from "strongly agree "(1) to" strongly disagree" (5) .
The sum of scores are calculated from 0 to 100.
The higher the score, the higher the level of regret.
|
one month after treatment (T2)
|
|
Decision control preference
Time Frame: before the counseling (T0), immediately after counseling(T1)
|
Decision control preference was measured by Decision control preference Scale(DCPS) .The scale asks two question:(1)control preference measured at before the counseling; (2) actual decision control level measured after counseling immediately.
|
before the counseling (T0), immediately after counseling(T1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 15, 2021
Primary Completion (Anticipated)
June 30, 2022
Study Completion (Anticipated)
August 31, 2022
Study Registration Dates
First Submitted
July 26, 2021
First Submitted That Met QC Criteria
July 26, 2021
First Posted (Actual)
August 2, 2021
Study Record Updates
Last Update Posted (Actual)
August 9, 2021
Last Update Submitted That Met QC Criteria
August 1, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202104009RINA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Decision Making
-
Massachusetts General HospitalUnknownDecision Making | Video Decision AidsUnited States
-
Brigham and Women's HospitalCompleted
-
University of ZurichPfizerCompletedDecision MakingSwitzerland
-
University Hospital, Clermont-FerrandCompleted
-
Umraniye Education and Research HospitalCompleted
-
University of UtahNational Institutes of Health (NIH)Completed
-
Rush University Medical CenterNot yet recruiting
-
Rutgers, The State University of New JerseyNational Institute on Drug Abuse (NIDA)Recruiting
-
Boston CollegeCompleted
-
Instituto Tecnologico y de Estudios Superiores...Completed
Clinical Trials on Question prompt list
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
Region Örebro CountyRecruitingNeoadjuvant Therapy | Shared Decision Making | Breast Cancer Early Stage Breast Cancer (Stage 1-3)Sweden
-
Georgetown UniversityH. Lee Moffitt Cancer Center and Research Institute; Barbara Ann Karmanos Cancer...Completed
-
University of Wisconsin, MadisonPatient-Centered Outcomes Research Institute; Brigham and Women's Hospital; Oregon... and other collaboratorsCompleted
-
University of North Carolina, Chapel HillNational Center for Advancing Translational Sciences (NCATS); RTI InternationalCompleted
-
Stanford UniversityCompletedPain | Arthritis | Tendon Injuries | Sprains | Tumor | Fracture | StrainsUnited States
-
Stanford UniversityCompletedGanglion Cysts | Carpal Tunnel Syndrome | Trigger Finger | Dupuytren Contracture | Trigger ThumbUnited States
-
University of North Carolina, Chapel HillAgency for Healthcare Research and Quality (AHRQ)CompletedGlaucomaUnited States
-
University of North Carolina, Chapel HillPatient-Centered Outcomes Research InstituteCompleted
-
Washington University School of MedicineRecruitingLymphoma | Multiple MyelomaUnited States